HOSPIRA, INC. v. FRESENIUS KABI USA, LLC

2019-1329, 2019-1367.

946 F.3d 1322 (2020)

HOSPIRA, INC., Plaintiff-Appellant v. FRESENIUS KABI USA, LLC, Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Decided: January 9, 2020.


Attorney(s) appearing for the Case

Adam G. Unikowsky , Jenner & Block LLP, Washington, DC, argued for plaintiff-appellant. Also represented by Bradford Peter Lyerla , Aaron A. Barlow , Yusuf Esat , Ren-How Harn , Sara Tonnies Horton , Chicago, IL.

Imron T. Aly , Schiff Hardin LLP, Chicago, IL, argued for defendant-appellee. Also represented by Kevin Michael Nelson , Joel M. Wallace ; Ahmed M.T. Riaz , New York, NY.

Before Lourie, Dyk, and Moore, Circuit Judges.


Hospira Inc. ("Hospira") appeals from the judgment of the United States District Court for the Northern District of Illinois that claim 6 of U.S. Patent 8,648,106 ("the '106 patent") is invalid as obvious. Hospira, Inc. v. Fresenius Kabi USA, LLC, 343 F.Supp.3d 823 (N.D. Ill. 2018) ("Opinion"). Because we find...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases